Gynecologic Cancer
From the Journals
Epacadostat plus pembrolizumab shows promise in advanced solid tumors
Investigational drug epacadostat plus pembrolizumab demonstrated promising antitumor activity and safety in patients with advanced solid tumors....
From the Journals
Dramatic response from pembrolizumab in patient with Lynch syndrome
A woman with two distinct primary tumors caused by Lynch syndrome achieved complete regression of both after pembrolizumab therapy.
From the Journals
Posttherapy HPV DNA a bad omen in cervical cancer
Women with detectable plasma human papillomavirus DNA at the end of chemoradiation were at increased risk for recurrence.
From the Journals
Pruritus linked to wide variety of cancers
The odds of specific cancers vary by race.
From the Journals
FILM: Rave review for indocyanine green in lymphatic mapping
Fluorescent indocyanine green under near infrared spotted significantly more lymph nodes in patients with cancer than isosulfan blue under white...
From the Journals
Cervical cancer screening recommendations vary by age and risk
Guidelines
First-ever gestational trophoblastic neoplasia guidelines published
These rare tumors of pregnancy are generally curable with the appropriate risk-based therapies, experts say.
From the Journals
VEGF inhibitor shows promise in platinum resistant/refractory ovarian cancer
Combining the vascular endothelial growth factor (VEGF) receptor–targeting tyrosine kinase inhibitor apatinib with oral etoposide in people with...
Conference Coverage
Phase 2 trial: Dendritic cell vaccine maintenance prolongs PFS in EOC
DCVAC maintenance after chemotherapy prolonged progression-free survival by almost 6 months in EOC patients who have undergone primary debulking...
Latest News
PARP inhibitors didn’t impair QOL as ovarian cancer maintenance therapy
Despite significant hematologic toxicities, PARP inhibitors did not adversely affect health-related quality of life for ovarian cancer patients....
From the Journals
ACA coverage mandate leads to more insurance for young women, early gynecologic cancer diagnoses
“These insurance gains have huge impacts on people’s lives,” Dr. Smith stated.